metricas
covid
Buscar en
Clinics
Toda la web
Inicio Clinics Larotrectinib versus infigratinib for adult patients with both glioma and tyrosi...
Journal Information

Statistics

Follow this link to access the full text of the article

Original articles
Larotrectinib versus infigratinib for adult patients with both glioma and tyrosine kinase alterations after failure of initial therapies: Efficacy and safety analysis
Yufang Chena,1, Jian Mab,1, Qianqian Gaoa, Yu Gaia, Yichi Suna, Meihua Wanga,
Corresponding author
wangmeihua1234@suda.edu.cn

Corresponding author.
a Department of Pathology, Changzhou Tumor Hospital, Changzhou, Jiangsu, China
b Department of Oncology, Changzhou Tumor Hospital, Changzhou, Jiangsu, China
Read
608
Times
was read the article
209
Total PDF
399
Total HTML
Share statistics
Article information
ISSN: 18075932
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 35 12 47
2024 October 47 22 69
2024 September 45 22 67
2024 August 41 17 58
2024 July 39 25 64
2024 June 23 6 29
2024 May 35 17 52
2024 April 39 21 60
2024 March 45 19 64
2024 February 50 48 98

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos